TB (Quiz 2) Flashcards

1
Q

What is TB?

A
  • ○scientific name: mycobacterium tuberculosis
  • ○acid fast, aerobic bacteria
  • ○grows rapidly - divides every 15-20 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is TB spread?

A
  • ○droplets expelled when someone with active TB coughs, sneezes, speaks
  • ○TB NOT spread through:
    • ■shaking hands
    • ■sharing drinks
    • ■kissing
    • ■sharing toothbrushes
  • ○pulmonary TB most common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pathogenesis of TB

A
  • •droplets with bacilli inhaled and travel to alveoli
  • •macrophages in alveoli ingest bacilli
    • •macrophages attract phagocytes to form a shell (granuloma) around bacilli
      • •most bacilli are destroyed or controlled - latent TB
      • •process can take up to 8 weeks
    • •some bacilli survive and multiply intracellularly
      • •they are released when macrophage dies - active TB
  • •disseminated through lymphatic system and bloodstream
  • •other immune cells, such as dendritic cells, may become involved
  • •extrapulmonary TB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Epidemiology: TB by the numbers

***

A
  • •in 1989, the CDC announced a goal of eradication of TB in the US by 2010
    • •Also part of the Millennium Development Goals
  • •Status of TB in the US per CDC reports:
    • •since 1992, incidence rates have ↓ by 3-10%/year
    • •9,565 total TB cases reported in 2013
      • •in 2014, total cases for ages 0-24 was 1421
    • •in 2013, 555 affected persons (0.2%) died from TB
  • •Worldwide, rates are quite higher:
    • •9.6 million new cases in 2014
      • •1.0 mil = children
    • •TB is listed as a leading cause of death
    • •in 2014, 1.5 million died worldwide from TB
      • •140,000 = children
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mapping TB: in the US

***

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

For the Provider: Questions to ask to assess risk for TB

A
  • •where are you from?
    • •if not US: when do you move here?
  • •have you or someone you know ever had a positive PPD or TB test?
  • •have you or someone you know ever had TB? Been treated for TB?
  • •have you traveled outside of the US?
    • •If so, when, how long, where?*
  • •do you work/reside in a crowded place (jail or homeless shelter)?
  • •is there anyone at home who is immunocompromised?
  • *AAP guidelines say >1wk in high risk area puts individual at risk vs. WHO says >1mo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

For the Provider: Questions to ask to assess risk for infection

A
  • •Are you (child) currently experiencing any of the following?:
    • •cough
    • •coughing up blood
    • •fever
    • •weight loss or failure to thrive
    • •tiredness/lethargy
    • •feeling sick
    • •night sweats
  • *However young children often do not show these symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

For the provider: •Other potentially helpful questions:

A
  • •have you (child) ever had the BCG vaccine?
  • •have you (child) ever had a chest x-ray? why and results?
  • •are/have you (child) taken medications?
  • •which medications? why?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

High risk for TB

***

A
  • •close contact with person(s) with known/suspected TB
  • •foreign-born individuals from high risk countries: Africa, Asia, Latin America, Eastern Europe
  • •travel abroad
  • •individuals who reside or work in congregate settings: jail, homeless shelter
  • •health care workers
  • •immunocompromised patients
  • •certain populations including medically underserved, low-income, and those who abuse drugs/alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Signs and Symptoms of Pulmonary TB (more common)

on ROS

***

A
  • ○a bad cough lasting 3+ weeks (dry or productive)
  • ○chest pain
  • ○coughing up blood or sputum
  • ○weakness/fatigue
  • ○loss of appetite
  • ○weight loss
  • ○chills
  • ○fever
  • ○night sweats
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Signs and Symptoms of Pulmonary TB (more common)

on exam

***

A
  • ○VS: fever
  • ○LAD
  • ○actelectasis
  • ●*may have no symptoms!!*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Extrapulmonary TB?

***

A
  • ●less common than pulmonary TB but is common in pts with both HIV and TB
  • ●often disseminated through blood
  • ●if CNS involvement, can cause meningitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sx of extrapulmonary TB on ROS and exam

***

A
  • ○LAD (chronic or generalized)/lymphadenitis
  • ○malaise
  • ○headache
  • ○fever
  • ○personality changes
  • ○back pain
  • ○abdominal pain
  • ○vomiting or diarrhea
  • ○melena or blood in urine…
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Active vs. Latent TB

A
  • •so far what we have discussed is active… recap:
    • •active infection with s/s present
    • •can spread disease
  • •Latent:
    • •TB is present but the immune system has fought off active infection
    • •no s/s to indicate its presence
    • •might only be picked up incidentally or if asked the right questions
    • •person is not infectious and cannot spread TB to others
    • •when the immune system can no longer fight off TB, latent stage → active infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Reactivation TB?

Who is at risk?

A
  • •AKA chronic, secondary, or post-primary tuberculosis
  • •occurs in previously infected individual who had not fully healed
  • •can go undiagnosed for a long time (years)
  • •presents with similar symptoms but may have additional complications from long-term disease
  • •are at risk for reactivation if:
    • •immunocompromised or comorbid condition
    • •recent TB infection (within the past 2 years)
    • •was not treated properly for TB in the past
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Image summary: TB

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Differentials for TB

A
  • •Depending on the presentation consider…:
  • •cancer
  • •GERD
  • •FUO
  • •Lymphadenopathy/lymphadenitis
  • •fibrotic lung disease
  • •anorexia nervosa
  • •other infections (pneumonia, CMV, histoplasmosis)
  • •other chronic conditions (diabetes, HIV, lupus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Screening Tests for Tuberculosis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Tuberculin Skin Test (TST): describe how it’s done and read

A
  • Standard method for children of all ages (birth and up):
  • •TB antigens = purified protein derivative (PPD)
  • •0.1mL intradermal injection
  • •6-10mm elevation of skin (a wheal)
  • •Read 48-72 hours after administration
  • •Measured in millimeters of INDURATION
  • •palpable, raised, hardened area/swelling,
  • •not erythema
20
Q

Skin Test Interpretation in children

A
  • Positive results:
  • Induration of 5mm
    • •close contact with known or suspected people with TB disease
    • •suspected to have TB disease
    • •with immunosuppressive conditions/receiving immunosuppressive therapy
  • Induration of 10mm or more
    • •less than 4 years old
    • •with other medical conditions (ex. Hodgkin disease, lymphoma, DM)
    • •Recent immigrants, born from or travel to high-incidence countries
    • •Resident of/exposed to high risk congregate settings
  • Induration of 15mm or more
    • •age 4 and older with no known risk factors
21
Q

TST: when might you see false positives or negatives

A
  • False positive may seen with:
    • •infection with nontuberculous mycobacteria
    • •improper administration
    • prior BCG vaccinations ONLY if child was vaccinated in the last 2-3 months. rare after a couple months.
  • False negative may be observed:
    • •In setting of recent TB exposure (within 8-10 weeks)= test 8012w after exposure
    • •Infants < 6 months old
22
Q

What is Interferon-Gamma Release assay (IGRA)

types, advantages

A
  • •Blood test that measures immune system reactivity to Mycobacterium tuberculosis
  • •Types:
    • •QuantiFERON-TB Gold In-Tube test (QFT-GIT)
    • •T-SPOT - TB test
  • •Advantages:
    • •Single patient visit
    • •Result within 24 hours
    • •Recent BCG vaccination does not cause false positive results
  • •Preferred use for children > 5 yo
  • •Evidence for IGRA use in children is limited
23
Q

What to do with positive results of TB tests?

Is it recommended to do >1 test?

A
  • •TST or IGRA are used to screen for both TB disease or latent TB infection
  • •Positive results can mean latent or active TB infection
  • •Not recommended to do both tests
  • •Other evaluation/clinical evidence must follow to distinguish diagnosis
24
Q

Chest Radiography – F/U Screening

What type of CXR to order

A
  • •Frontal and lateral chest radiography
    • •Confirms or rules out pulmonary/intrathoracic TB, if positive skin/blood test and/or asymptomatic
25
Q

Chest Radiography: most commonfindings in children / adolescents with TB

A
  • •Most common positive finding in children with TB:
    • •Primary complex consisting of opacification with hilar or subcarinal lymphadenopathy, in the absence of notable parenchymal involvement
    • •Most are asymptomatic
  • •Adolescents with TB
    • •Typical adult disease findings
    • •Upper lobe infiltrates, pleural effusions, cavitation
26
Q

Negative vs Positive Film Findings - Child

A

HILAR LAD in pic #2

27
Q

Negative vs Positive Film Findings -Adolescent

A

2 is upper lobe infiltrates

28
Q

Two main ways to obtain smear and culture for diagnosis:

A
  • •Sputum sample
    • •Suggested for adolescents
      • •Difficult to obtain in young children = insufficient tussive force
    • •Sputum induction may be used
      • •Admin. aerosolized heated saline + salbuterol → suction
      • •Suggested safer than gastric aspiration
  • Gastric aspiration
    • •Primary method for young children
    • •Early morning gastric contents collected from fasting child
      • •3 samples on different days
  • •Lumbar puncture for Children <12 months old suspected of having pulmonary or extrapulmonary TB
29
Q

Algorithm: what to do if suspicion for active pulmonary TB

A
  • If children < 4yo or high suspicion of active TB >>TREAT before getting back culture results
    • -Younger children have risk for rapid disease progression
    • -Example = abnormal chest x-ray, positive TST, positive smear
  • If low suspicion is low >> wait for cultures before treating
    • -Example = abnormal chest x-ray, negative TST, negative smear
  • Graph source: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068897/figure/F1/
30
Q

Diagnosis of Latent Tuberculosis Infection

A
  • Asymptomatic/no physical findings
  • Positive TST or IGRA
  • Normal Chest radiography

→ Consider treatment for prevention

31
Q

Treatment for Latent TB Infection: 1st line

A
  • •1st line: Isoniazid (INH)
    • •Daily for 6-9 months, well tolerated
    • •Monitor every 4-6 weeks for 3 months → every 2-3 months
      • •Assess for possible drug toxicity
      • •Side Effects: GI intolerance (n/v, abd pain), dark urine(color of coke), rash, fatigue, risk of hepatotoxicity
      • •Baseline or routine LFTs not recommended

  • The preferred regimen for children aged 2 to 11 years is 9 months of daily INH.*
  • Isoniazid on an empty stomach, liquid option available*
32
Q

Treatment for Latent TB Infection: 2nd line

A
  • •2nd line: Isoniazid+Rifapentine (INH-RPT) OR Rifampin
    • •INH-RPT = Directly observed treatment for 2-17 yo, another regimen option for healthy patients > 12yo with risk for developing TB
    • Rifampin = daily for 4 months, for INH intolerance/resistant
    • •Side Effects: Nausea, anorexia, pruritis, orange discoloration of body fluids, hyperbilirubinemia
    • •Watch for drug interactions (ex. phenytoin >> increase levels; oral contraceptives à decrease blood levels)

  • INH-RPT = use if recent exposure to contagious TB, conversion from negative to positive on TST or IGRA, chest x-ray findings of healed pulmonary TB,*
  • -Do not give under 2 yo*
  • OCP drug interaction applies to both RPT and Rifampin à advices alternative contraceptive method*
33
Q

Diagnosis of Active TB Disease

A
  • •Clinical symptom(s) or asymptomatic
  • •History of contact or at high risk
  • •Positive TST or IGRA
  • •Abnormal Chest X-ray findings usually
  • •Positive sputum, possibly
  • → Needs treatment

  • Symptoms may include one or more of the following: fever, cough, chest pain, weight loss, night sweats, hemoptysis, fatigue, and decreased appetite.*
  • Chest radiograph is usually abnormal. However, may be normal in persons with advanced immunosuppression or extrapulmonary disease.*
  • The laboratory tests used to find TB in sputum are less likely to have a positive result in children because children are more likely to have TB disease caused by a smaller number of bacteria (paucibacillary disease). Also, difficult to collect sputum in younger children.*
  • Smear positive in about 50% of patients*
34
Q

Treatment for Active TB Disease

A
  • → Most likely to refer to a specialist!
    • •For first 2 months (Initial phase):
      • •INH + Rifampin (RIF) + Ethambutol + Pyrazinamide daily
    • •4 or 7 month continuation phase
      • •INH + RIF daily
    • •Monitor monthly
      • •Disease progression, adherence, drug toxicity
    • •Sputum cultures monthly after initial phase until 2 consecutive negative cultures
    • •Follow up chest x-ray not necessary
35
Q

Drug-Resistant Tuberculosis

what is it / when to suspect

A
  • •Resistant to Isoniazid and Rifampin
  • •Suspect if…
    • •TB treatment failure à positive sputum smear/culture after 4 months of treatment OR drug susceptibility test
    • •TB in a region with known high drug-resistance rates
    • •Contact with drug-resistant TB
36
Q

Drug-Resistant Tuberculosis

Dx and Tx

A
  • •Optimal tx for children is uncertain, but recommend Fluoroquinolone for tx
  • •Nucleic acid tests/assay for diagnosis:
    • •GeneXpert MTB/RIF, MTBDRplus, MTBDR
  • •Management difficult → Expert consultation important!

Important to get smear/culture after 2 months of TB treatment (active) to assess if treatment is working/ risk of drug resistance à result should be negative by 2 months, if not get drug susceptivility

37
Q

Bacille Calmette-Guerin (BCG) Vaccine

what is it, what does it protect against?

A
  • •Vaccine to prevent TB and other mycobacterial infections
    • •Meningitis and disseminated TB (Military)
  • •Protects against extrapulmonary, but not latent pulmonary
38
Q

Bacille Calmette-Guerin (BCG) Vaccine

when is it recommended in US, efficacy, implications for TB screening

A
  • •U.S.A. = recommended only for immune-competent children with high risk of exposure
  • •Efficacy depends on extent of prior exposure & age
    • •No exposure = more benefit
    • •Less effective with age
  • •May cause false positive TST 2-3 months after vaccination
  • •At risk children should still get screened/tested even if vaccinated by BCG
39
Q

Other Vaccines to be aware of in screening for TB

A
  • •Vaccination with live viruses (ex. Measles) can interfere with TST reactions >> suppress (+) results
    • •Skin testing must be given…
      • •Same day as the live-virus vaccination (OR)
      • •4-6 weeks after vaccine administration (OR)
      • •One month after smallpox vaccination
    • •Effect of live-virus vaccination on IGRA has not been studied
40
Q

Recommendations for screening and tx in adolescent mothers: nursing or pregnant

A
  • Adolescent mothers - nursing or pregnant
    • •Pregnancy: Screen and treat if at high risk for latent to active
      • •Tx choice: Isoniazid + pyridoxine supplement
    • Should have pretreatment LFT test, first 2 months
      • •No BCG vaccination with pregnancy
    • •Breastfeeding: not contraindicated if treated w/ first line agents
      • •Do not breastfeed if treating for drug-resistant TB
41
Q

Recommendations for screening and tx in HIV infected or immunosuppressed

A
  • •Important test: Sputum samples, lymph node aspiration if needed, Xpert MTB/RIF assay for rapid diagnosis
  • •Positive if TST is >5mm, more likely to be negative w/ low CD4
42
Q

Recommendations for screening in international adoptees

A
  • •Initial screening 2 weeks after arrival – screening, TST and HIV testing performed
  • >>If negative TST = recommend repeat TST/IGRA 3 months after initial TST
  • •Follow up visit 6 months after initial visit, unless earlier visit warranted
  • •If child has symptoms, sputum tests required (even if TST/IGRA and chest x-ray negative)
  • •If known HIV infection, chest x-ray AND sputum tests required
  • •If treated, DOT = Directly Observed Therapy >> provider watches child swallow or take each dose of medication, 6 months to complete
  • ? of overestimation of latent tb in international adoptees. More w/TST than IGRS - recommend getting IGRA if TST +
43
Q

Monitoring and future surveillance if + TST

A
  • •Patients with documented positive TST should not repeat the skin test
    • •Repeat testing has no clinical utility for assessing effectiveness of treatment
  • •Ongoing potential TB exposure + positive TBT history → should get baseline chest x-ray
  • •Recommend screening for HIV if positive latent or active TB
44
Q

When to report…

A
  • •Must contact and report to local or state TB control program if…
    • •In contact with a positive TB disease
    • •Child had contact with someone with TB disease
    • •Do not need to report latent TB infection
45
Q

Community resource for kids w/TB

A
  • The Winchester Chest Clinic - YNHH
    • •Only specialized pediatric tuberculosis outpatient clinic in Connecticut
    • •Dr. Robert Baltimore
    • •Located at 789 Howard Avenue, New Haven
46
Q

Key points for exam

A
  • Key points for Tuberculosis
  • World wide risks and high risk populations in US.
  • Epidemiology and pathophysiology
  • Unique factors about TB in children
    • Risks
    • Transmission
    • Presentation
  • Screening recommendations for children
    • Risk levels
    • Types of screening TST, IGRA
    • Timing of screening
      • From possible exposure (2-10 weeks)
      • Relationship to immunizations especially MMR
    • Facts about BCG
    • Interpretation of screening
  • Latent and active disease
    • Definitions
    • Approaches to distinguishing
      • Risk assessment
      • CXR findings
    • Risks of LTBI and active
    • Management
    • Public health ramifications